RICHARD HURWITZ to Genetic Vectors
This is a "connection" page, showing publications RICHARD HURWITZ has written about Genetic Vectors.
Connection Strength
1.123
-
Inhibitors of metalloprotease, ?-sectretase, protein kinase C and Rho kinase inhibit wild-type adenoviral replication. PLoS One. 2020; 15(7):e0236175.
Score: 0.531
-
The liberation of CD44 intracellular domain modulates adenoviral vector transgene expression. J Biol Chem. 2012 Sep 21; 287(39):32697-707.
Score: 0.306
-
Versican G1 domain enhances adenoviral-mediated transgene expression and can be modulated by inhibitors of the Janus kinase (JAK)/STAT and Src family kinase pathways. J Biol Chem. 2017 09 01; 292(35):14381-14390.
Score: 0.108
-
Absence of systemic immune response to adenovectors after intraocular administration to children with retinoblastoma. Mol Ther. 2010 Oct; 18(10):1885-90.
Score: 0.066
-
Efficient gene transfer into retinal cells using adenoviral vectors: dependence on receptor expression. Invest Ophthalmol Vis Sci. 2004 Jun; 45(6):1680-7.
Score: 0.043
-
Immune consequences of intraocular administration of modified adenoviral vectors. Hum Gene Ther. 2001 May 01; 12(7):833-8.
Score: 0.035
-
Modulation of adenoviral transduction in vitro and in vivo by hyaluronan and its receptor CD44. Mol Ther. 2007 Mar; 15(3):566-70.
Score: 0.013
-
Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir. J Clin Oncol. 2005 Nov 01; 23(31):7927-35.
Score: 0.012
-
Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes. Hum Gene Ther. 2001 Apr 10; 12(6):659-70.
Score: 0.009